Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Dividend Payout Ratio : 0.00 (As of Jan. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Dividend Payout Ratio?

Cotinga Pharmaceuticals's dividend payout ratio for the months ended in Jan. 2020 was 0.00.

The historical rank and industry rank for Cotinga Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

COTQF's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-22), the Dividend Yield % of Cotinga Pharmaceuticals is 0.00%.

Cotinga Pharmaceuticals's Dividends per Share for the months ended in Jan. 2020 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Cotinga Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for Cotinga Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Dividend Payout Ratio Chart

Cotinga Pharmaceuticals Annual Data

Trend

Apr10

Apr11

Apr12

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dividend Payout Ratio

Get a 7-Day Free Trial

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cotinga Pharmaceuticals's Dividend Payout Ratio

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Dividend Payout Ratio falls into.

Cotinga Pharmaceuticals Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Cotinga Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Apr. 2019 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Apr. 2019 )	/	EPS without NRI (A: Apr. 2019 )
	=	0	/	-0.092
	=	N/A

Cotinga Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Jan. 2020 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2020 )	/	EPS without NRI (Q: Jan. 2020 )
	=	0	/	-0.015
	=	N/A

Cotinga Pharmaceuticals (OTCPK:COTQF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Cotinga Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018